Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Sharpless focus on pediatric cancer

What Trump’s State of the Union pediatric cancer promise means

National Cancer Institute Director Norman “Ned” Sharpless hopes to parlay a State of the Union pediatric cancer funding commitment into a big data initiative that could serve as a model for advancing the search for cures for all kinds of cancer.

“Many childhood cancers have not seen new therapies in decades,” President Trump said in the State of the Union address. “My budget will ask the Congress for $500 million over the next 10 years to fund this critical life-saving research.”

The Trump administration has not released details of the initiative, but Sharpless outlined some in a Feb. 14 conference call with hundreds of pediatric cancer advocates. Emphasizing the administration’s support for the initiative, Sharpless was joined on the call by Lance Leggitt, deputy assistant to the president for domestic

Read the full 1291 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers